Efficacy and Safety of Oral E5501 Plus Standard of Care for the Treatment of Thrombocytopenia in Adults With Chronic Immune Thrombocytopenia (Amendment 02)
Clinical trial NCT01438840 · COMPLETED
Trial details
- NCT number
- NCT01438840
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-16
- Primary completion
- 2013-11-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.